苯巴那酯（Ontozry）是治疗什么的？用法用量是怎样的？

Phenobarnate (Ontozry), which was launched in the United States in 2019, attracted the attention of many patients as soon as it was launched. This drug is a prescription drug discovered and developed by South Korea's SK Biopharmaceutical Company (SK) and its American subsidiary SK Life Sciences. Today let's take a detailed look at what (Ontozry) treats? What is the usage and dosage?

Phenobarnate (Ontozry) can be used to treat partial-onset epilepsy in adults. Epilepsy is the second most common neurological disease in China after headache. It is a chronic disease caused by sudden abnormal discharge of brain nerves, leading to temporary brain dysfunction. Phenobanate is a sodium channel blocker that reduces the repetitive release of electrical impulses from nerve cells, but the mechanism by which the drug works is currently unclear. Phenobarnate (Ontozry) reduces the frequency of epileptic seizures and has a significant therapeutic effect. However, this drug is not currently on the market in China. Patients in need can obtain the overseas version of this product through Medical Companion Travel.

So, what is the dosage of Ontozry? Phenobarate (Ontozry) is available in many specifications, including 12.5mg; 25mg; 50mg; 100mg; 150mg; 200mg. Both monotherapy and adjuvant therapy are taken orally once a day. Initial dose of Phenobarate: 12.5 mg once a day in weeks 1 and 2; maintenance dose: once a day in the 11th week and thereafter 200 mg once a day; the gradual increase plan for this drug is 25 mg once a day in the 3rd and 4th weeks; 50 mg once a day in the 5th and 6th weeks; 100 mg once a day in the 7th and 8th weeks; 150 mg once a day in the 9th and 10th weeks. Patients should not increase or decrease the dose of this product at will, let alone stop the medication at will, and must follow the doctor's advice.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: